Sally Beer
Impact in
- Infectious Diseases top 1%
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
- SARS-CoV-2 detection and testing
-
- Trauma, Hemostasis, Coagulopathy, Resuscitation
Papers in
-
- COVID-19 Clinical Research Studies 7
- SARS-CoV-2 and COVID-19 Research 6
- SARS-CoV-2 detection and testing 3
- Viral gastroenteritis research and epidemiology 2
- Co-authors
- Simon J. Stanworth (1 shared paper)Giles R. Nordmann (1 shared paper)Laura A. Pankhurst (1 shared paper)Heidi A. Doughty (1 shared paper)Karim Brohi (1 shared paper)Nicola S. Curry (1 shared paper)Helen Lucy Thomas (1 shared paper)C. P. Rourke (1 shared paper)
- Journals
- The Lancet (7 papers)Nature (4 papers)JAMA (4 papers)Nature Communications (3 papers)JAMA Network Open (2 papers)
- Partner nations
- United KingdomAustraliaUnited States
In The Last Decade
Sally Beer
48 papers receiving 3.7k citations
Sally Beer's Hit Papers
Peers
Comparison fields: 5 of 131
- Infectious Diseases 1.7k
- Critical Care and Intensive Care Medicine 284
- Applied Microbiology and Biotechnology 68
- Neurology 467
- Internal Medicine 75
Countries citing papers authored by Sally Beer
This map shows the geographic impact of Sally Beer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sally Beer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sally Beer more than expected).
Fields of papers citing papers by Sally Beer
This network shows the impact of papers produced by Sally Beer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sally Beer. The network helps show where Sally Beer may publish in the future.
Co-authors
The 25 scholars most cited alongside Sally Beer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 49 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial Hit paper breakdown → | 2021 | 403 |
| 2 | Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial Hit paper breakdown → | 2021 | 381 |
| 3 | Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial Hit paper breakdown → | 2022 | 282 |
| 4 | 2020 | 281 | |
| 5 | Effects of a high-dose 24-h infusion of tranexamic acid on death and thromboembolic events in patients with acute gastrointestinal bleeding (HALT-IT): an international randomised, double-blind, placebo-controlled trial Hit paper breakdown → | 2020 | 271 |
| 6 | Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis Hit paper breakdown → | 2022 | 230 |
| 7 | Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial Hit paper breakdown → | 2021 | 211 |
| 8 | A blood atlas of COVID-19 defines hallmarks of disease severity and specificity Hit paper breakdown → | 2022 | 209 |
| 9 | Neutrophils and emergency granulopoiesis drive immune suppression and an extreme response endotype during sepsis Hit paper breakdown → | 2023 | 183 |
| 10 | 2020 | 171 | |
| 11 | 2015 | 145 | |
| 12 | GWAS and meta-analysis identifies 49 genetic variants underlying critical COVID-19 Hit paper breakdown → | 2023 | 121 |
| 13 | Adeno-associated virus 2 infection in children with non-A–E hepatitis Hit paper breakdown → | 2023 | 109 |
| 14 | Genomic investigations of unexplained acute hepatitis in children Hit paper breakdown → | 2023 | 92 |
| 15 | 2023 | 83 | |
| 16 | 2021 | 71 | |
| 17 | 2021 | 70 | |
| 18 | 2021 | 57 | |
| 19 | 2023 | 56 | |
| 20 | 2021 | 55 |
About Sally Beer
Sally Beer is a scholar working on Infectious Diseases, Critical Care and Intensive Care Medicine, Immunology, Epidemiology and Pediatrics, Perinatology and Child Health, having authored 49 papers that have together received 3.8k indexed citations. Recurring topics across this work include COVID-19 Clinical Research Studies (7 papers), SARS-CoV-2 and COVID-19 Research (6 papers), SARS-CoV-2 detection and testing (3 papers), Viral gastroenteritis research and epidemiology (2 papers), Diabetes and associated disorders (2 papers), Pediatric Pain Management Techniques (2 papers), Asthma and respiratory diseases (2 papers) and Animal Virus Infections Studies (2 papers). The work is most often cited by research in Infectious Diseases (1.7k citations), Critical Care and Intensive Care Medicine (284 citations), Applied Microbiology and Biotechnology (68 citations), Neurology (467 citations) and Internal Medicine (75 citations). Sally Beer has collaborated with scholars based in United Kingdom, Australia and United States. Frequent co-authors include Simon J. Stanworth, Giles R. Nordmann, Laura A. Pankhurst, Heidi A. Doughty, Karim Brohi, Nicola S. Curry, Helen Lucy Thomas, C. P. Rourke, Alison J. Deary and Laura Green. Their work appears in journals such as The Lancet, Nature, JAMA, Nature Communications and JAMA Network Open.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.